BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12135483)

  • 21. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.
    Lee BK; Diebel E; Neukam FW; Wiltfang J; Ries J
    Int J Oncol; 2001 Nov; 19(5):1063-8. PubMed ID: 11605010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
    Yi X; White DM; Aisner DL; Baur JA; Wright WE; Shay JW
    Neoplasia; 2000; 2(5):433-40. PubMed ID: 11191110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity and telomerase subunit gene expression levels are not related in prostate cancer: a real-time quantification and in situ hybridization study.
    Kamradt J; Drosse C; Kalkbrenner S; Rohde V; Lensch R; Lehmann J; Fixemer T; Bonkhoff H; Stoeckle M; Wullich B
    Lab Invest; 2003 May; 83(5):623-33. PubMed ID: 12746472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells.
    Xu D; Erickson S; Szeps M; Gruber A; Sangfelt O; Einhorn S; Pisa P; Grandér D
    Blood; 2000 Dec; 96(13):4313-8. PubMed ID: 11110707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells.
    Uchida N; Otsuka T; Shigematsu H; Maeda M; Sugio Y; Itoh Y; Niho Y
    Leuk Res; 1999 Dec; 23(12):1127-32. PubMed ID: 10613358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.
    Beattie TL; Zhou W; Robinson MO; Harrington L
    Mol Biol Cell; 2000 Oct; 11(10):3329-40. PubMed ID: 11029039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle.
    Vogan JM; Collins K
    J Biol Chem; 2015 Aug; 290(35):21320-35. PubMed ID: 26170453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells.
    Koyanagi Y; Kobayashi D; Yajima T; Asanuma K; Kimura T; Sato T; Kida T; Yagihashi A; Kameshima H; Watanabe N
    Anticancer Res; 2000; 20(2A):773-8. PubMed ID: 10810353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line.
    Fu XH; Zhang JS; Zhang N; Zhang YD
    World J Gastroenterol; 2005 Feb; 11(6):785-90. PubMed ID: 15682468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of hTERT and hTR in cis reconstitutes and active human telomerase ribonucleoprotein.
    Bachand F; Kukolj G; Autexier C
    RNA; 2000 May; 6(5):778-84. PubMed ID: 10836798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
    Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
    Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
    Chen W; Xiong X; Zhou H; Zhou Q
    Chin Med J (Engl); 2002 Feb; 115(2):290-2. PubMed ID: 11940351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
    Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
    Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component.
    Masutomi K; Kaneko S; Hayashi N; Yamashita T; Shirota Y; Kobayashi K; Murakami S
    J Biol Chem; 2000 Jul; 275(29):22568-73. PubMed ID: 10811633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biochemical role of the heat shock protein 90 chaperone complex in establishing human telomerase activity.
    Keppler BR; Grady AT; Jarstfer MB
    J Biol Chem; 2006 Jul; 281(29):19840-8. PubMed ID: 16714764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
    Kawauchi K; Ihjima K; Yamada O
    J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
    Ulaner GA; Hu JF; Vu TH; Oruganti H; Giudice LC; Hoffman AR
    Int J Cancer; 2000 Feb; 85(3):330-5. PubMed ID: 10652422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.